4.4 Article

Impact of DaTscan Imaging on Clinical Decision Making in Clinically Uncertain Parkinson's Disease

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

Clinical utility of DaTscan imaging in the evaluation of patients with parkinsonism: a US perspective

Stuart H. Isaacson et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)

Article Clinical Neurology

Clinical Impact of 123I-Ioflupane SPECT (DaTscan) in a Movement Disorder Center

Allison K. Graebner et al.

NEURODEGENERATIVE DISEASES (2017)

Review Clinical Neurology

Clinical utility of DaTscan imaging in the evaluation of patients with parkinsonism: a US perspective

Stuart H. Isaacson et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

The Impact of DaTscan in the Diagnosis of Parkinson Disease

Isis Gayed et al.

CLINICAL NUCLEAR MEDICINE (2015)

Review Clinical Neurology

MDS clinical diagnostic criteria for Parkinson's disease

Ronald B. Postuma et al.

MOVEMENT DISORDERS (2015)

Article Clinical Neurology

Is There a Role for DAT-SPECT Imaging in a Specialty Movement Disorders Practice?

Danny Bega et al.

NEURODEGENERATIVE DISEASES (2015)

Article Clinical Neurology

Experience with DaTscan at a tertiary referral center

Suja Sadasivan et al.

PARKINSONISM & RELATED DISORDERS (2015)

Article Clinical Neurology

Role of DaTSCAN and clinical diagnosis in Parkinson disease

Raul de la Fuente-Fernandez

NEUROLOGY (2012)

Review Clinical Neurology

The role of DAT-SPECT in movement disorders

G. Kaegi et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)

Review Ophthalmology

Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review

Evita Evangelia Christou et al.

Summary: The retina may serve as a predictive factor for neurodegenerative disorders, with recent use of Optical Coherence Tomography Angiography (OCT-A) in studying macular microcirculation changes in Parkinson's disease (PD). While preliminary evidence suggests OCT-A could be a useful biomarker for cerebral vasculature in PD, further research is needed to confirm its predictive value in clinical practice.

SEMINARS IN OPHTHALMOLOGY